Business
PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange
BOSTON, April 29, 2026--PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange
About this update from Puretech Health Plc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":7367,"height":2362,"url":"https://media.zenfs.com/en/business-wire.com/411788e5295fe3317fab4648331f916a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/186x.xHilokdc_OYXaM8XA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMwOA--/https://media.zenfs.com/en/business-wire.com/411788e5295fe3317fab4648331f916a","width":960,"height":308},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/4vSWjmG.UPrDC.4nqgU.5A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03NzA-/https://media.zenfs.com/en/business-wire.com/411788e5295fe3317fab4648331f916a","width":1200,"height":385}},"lazy":false},{"type":"text","content":"PureTech to maintain its primary listing on the London Stock Exchange","length":69,"tagName":"p","attribs":{}},{"type":"text","content":"Simplification of listing structure expected to enhance operational efficiency and focus resources on advancing the Company’s portfolio","length":135,"tagName":"p","attribs":{}},{"type":"text","content":"BOSTON, April 29, 2026--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today announced that it has notified The Nasdaq Stock Market LLC ("Nasdaq") of its intention to voluntarily delist its American Depositary Shares ("ADSs"), each representing the right to receive ten (10) ordinary shares of the Company. Following the effectiveness of the delisting, PureTech’s ordinary shares will remain listed on the London Stock Exchange ("LSE"), which will continue to serve as the Company’s primary trading venue.","length":718,"tagName":"p"},{"type":"text","content":"Following a review of the Company’s listing structure and shareholder trading patterns, the Board of Directors determined that maintaining a dual listing is no longer necessary. The substantial majority of trading volume, liquidity, and price discovery for PureTech’s shares occurs on the LSE, and the majority of the Company’s current investor base as well as the Company’s governance framework are centered in the United Kingdom.","length":431,"tagName":"p"},{"type":"text","content":"This decision reflects PureTech’s ongoing c...